5 completed, 2 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Withdrawn 2 |
Follow Simeprevir: new trials by email Literature Review of Simeprevir trials Research Report on Simeprevir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT) Daclatasvir + Sofosbuvir, Simeprevir + Sofosbuvir - Hepatitis C, Chronic | Phase 4 | Completed | Federal University of São Paulo | 121 | 2015-12-01 | 2017-08-01 |
| Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1 Simeprevir, Sofosbuvir - PT-NANBH | Phase 4 | Withdrawn | Stanford University | 2015-09-01 | 2016-10-13 | |
| Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients Sofosbuvir 400mg/day/Simeprevir 150mg/day /Ribavirin 800mg/day for 12 weeks - Liver Cirrhosis | Phase 4 | Completed | Azienda Ospedaliera San Camillo Forlanini | 270 | 2015-01-01 | 2016-03-09 |
| Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a - Hepatitis C | Phase 4 | Completed | Tanta University | 10000 | 2015-01-01 | 2023-08-25 |
| SMV + SOF With/Without RBV for IFN-II Patients With CHC Simeprevir, Sofosbuvir, Ribavirin - Hepatitis C | Phase 4 | Completed | SC Liver Research Consortium, LLC | 24 | 2014-10-01 | 2018-06-19 |
| A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C Sofosbuvir + Simeprevir - Hepatitis C, Chronic, HIV CDC Category A1 | Phase 4 | Withdrawn | University of California, San Francisco | 2014-08-01 | 2019-06-13 | |
| The SIM-SOF Trial for Hepatitis C Pegylated Interferon alfa-2b, Simeprevir, Ribavirin - Chronic Hepatitis C | Phase 4 | Completed | Center For Hepatitis C, Atlanta, GA | 93 | 2013-12-01 | 2016-03-14 |
Hepatitis C (4) · Hepatitis C, Chronic (3) · Fibrosis (1) · Liver Cirrhosis (1)
Azienda Ospedaliera San Camillo Forlanini (1) · Center For Hepatitis C, Atlanta, GA (1) · Federal University of São Paulo (1) · SC Liver Research Consortium, LLC (1) · Stanford University (1) · Tanta University (1) · University of California, San Francisco (1)
United States (4) · Brazil (1) · Egypt (1) · Italy (1)
Adriano M Pellicelli, MD (1) · Anne Luetkemeyer, MD (1) · Asem Elfert, Prof (1) · Brian L Pearlman, MD (1) · Eslam Esmail, Ass Lecturer (1) · Hala M Elsabagh, Prof (1) · Lobna Abo ALi, Ass Prof (1) · Mindie H Nguyen, MD, MAS (1) · Mohamed Elkassas, Lecturer (1) · Paul Pockros, MD (1) · Sabry Abou Saif, Ass Prof (1) · Sherief Abd-Elsalam (1) · Taher Eldemerdash, Prof (1)
PMID 24997638, PMID 25557952, PMID 26890629, PMID 27782373, PMID 29535545, PMID 29906601, PMID 32356185